Adlai Nortye Ltd. American Depositary Shares

NASDAQ:ANL USA Biotechnology
Market Cap
$250.52 Million
Market Cap Rank
#12041 Global
#5261 in USA
Share Price
$8.02
Change (1 day)
+0.50%
52-Week Range
$0.88 - $10.63
All Time High
$15.00
About

Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E recept… Read more

Adlai Nortye Ltd. American Depositary Shares (ANL) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: -0.266x

Based on the latest financial reports, Adlai Nortye Ltd. American Depositary Shares (ANL) has a cash flow conversion efficiency ratio of -0.266x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-14.19 Million) by net assets ($53.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Adlai Nortye Ltd. American Depositary Shares - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Adlai Nortye Ltd. American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Adlai Nortye Ltd. American Depositary Shares Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adlai Nortye Ltd. American Depositary Shares ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Adlai Nortye Ltd. American Depositary Shares (2019–2024)

The table below shows the annual cash flow conversion efficiency of Adlai Nortye Ltd. American Depositary Shares from 2019 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $25.48 Million $-51.82 Million -2.033x -184.99%
2023-12-31 $79.40 Million $-56.65 Million -0.713x -498.30%
2022-12-31 $-241.29 Million $-43.22 Million 0.179x +994.79%
2021-12-31 $-185.43 Million $-3.03 Million 0.016x -93.78%
2020-12-31 $-131.56 Million $-34.59 Million 0.263x +22.25%
2019-12-31 $-69.38 Million $-14.92 Million 0.215x --